Overview of India's Diagnostics Industry

India’s diagnostics industry continues to grow as more people use diagnostic services for disease detection, monitoring, preventive healthcare, and specialised testing. The sector also offers expansion opportunities because a large part of the market remains fragmented.

• Around 80–85% of the market is estimated to consist of smaller and regional diagnostic providers.
• Pathology contributes around 58% of the sector’s revenue.
• Radiology contributes around 42% of the sector’s revenue.
• Preventive healthcare, lifestyle changes, rising health awareness, and growing healthcare needs are supporting demand.
• Competition and pricing pressure remain key challenges for diagnostic companies.
   

The diagnostics industry in India is growing as demand for healthcare and testing increases. A major part of this growth comes from higher test volumes rather than large increases in prices. Recent industry assessments also expect volume growth to remain an important driver.
Several factors are supporting this demand. These include longer life expectancy, lifestyle-related health conditions, greater health awareness, and increasing interest in preventive healthcare.
For example, a person may have gone for a blood test only after developing symptoms. With greater awareness of preventive care, the same person may now undergo regular health check-ups to identify possible problems earlier.
Government efforts to improve healthcare infrastructure and wider healthcare spending also support the industry's long-term growth potential.
The market remains highly fragmented. Around 80–85% is estimated to consist of smaller and regional diagnostic providers, while organised diagnostic chains form a much smaller part of the industry. Current industry research also continues to describe the sector as highly fragmented, although estimates can differ depending on what services are included.
This fragmentation creates opportunities for consolidation. Larger diagnostic companies may grow through acquisitions or by expanding their own networks. Consolidation is already an important feature of the sector.
Another opportunity comes from semi-urban and rural areas. Access to organised diagnostic services is generally more limited in these locations than in major cities, giving companies scope to expand their networks.
 

India’s diagnostics industry broadly includes two service areas: pathology and radiology. Pathology contributes around 58% of sector revenue, while radiology contributes around 42%.
Pathology involves laboratory testing of blood, urine, tissues, and other samples to help detect or monitor medical conditions. Radiology uses imaging techniques such as X-rays and MRI scans to examine structures inside the body.
Several organised diagnostic companies operate across these areas.

Dr. Lal PathLabs

Dr. Lal PathLabs has traditionally had a strong presence in northern India and serves both individual customers and institutional clients such as hospitals and other healthcare organisations.
Along with pathology testing, the company also provides radiology services. Its current radiology offerings include services such as X-rays, ultrasound, MRI, mammography, and bone-density-related imaging.
For example, pathology may involve testing a blood sample, while radiology may involve using an X-ray or MRI to examine a part of the body.

Metropolis Healthcare

Metropolis Healthcare has traditionally had a strong presence in western India while expanding its network into other regions.
The company has grown through a combination of organic expansion and acquisitions. Its FY2024-25 disclosures describe a network covering more than 750 towns, supported by a flexible, asset-light model, along with additions to its laboratory network and acquisitions.
An asset-light model does not necessarily mean that a company avoids all new physical investment. Instead, it may use partnerships, existing infrastructure, collection centres, and selected laboratory investments to expand without building every facility from the ground up.

Vijaya Diagnostics

Vijaya Diagnostics has a strong base in southern India and provides both pathology and radiology services.
Unlike businesses that depend heavily on institutional customers, Vijaya receives a large part of its business directly from individual consumers. In FY2024-25, its B2C segment contributed 93% of its business, supporting the point that direct consumer interactions are an important part of its model.
The company has also expanded beyond its traditional southern markets. Its operations include West Bengal, and its annual report discusses its expansion into Kolkata in eastern India.
Competition within the diagnostics industry has increased as digital healthcare platforms and lower-cost diagnostic providers have entered the market.
Companies such as Tata 1mg have expanded consumer access to diagnostic testing through digital channels and home collection. This type of competition can affect pricing and encourage established diagnostic businesses to focus on service range, quality, accessibility, and operating efficiency. Broader industry research also identifies online-first diagnostic platforms as a source of pricing competition.
 

India’s diagnostics industry has long-term growth opportunities because healthcare demand, preventive testing, and health awareness are increasing. Recent industry assessments continue to expect double-digit sector growth over the coming years.
The fragmented structure of the market also provides opportunities for consolidation. Organised diagnostic companies can expand by acquiring regional businesses or building their presence in locations where organised diagnostic services are limited.
However, growth also comes with challenges. Competition from established chains, regional laboratories, digital platforms, and other new entrants can put pressure on test prices and margins.
Urban markets can also become more competitive because several diagnostic providers may operate within the same location. In comparison, semi-urban and rural areas can offer additional room for expansion where access to organised diagnostic facilities remains limited.
Overall, the industry's future will depend on how companies balance expansion, pricing, service quality, technology, and operational efficiency. As demand for diagnostic testing increases, pathology and radiology are likely to remain important parts of India’s healthcare system.
 

India’s diagnostics industry is expanding as demand for preventive healthcare, routine testing, and specialised diagnostics grows. Pathology and radiology remain the two main service areas, while organised diagnostic chains continue to expand across different regions. The sector also has opportunities in semi-urban and rural markets, where access to organised testing may be limited. However, strong competition, pricing pressure, and a highly fragmented market remain key challenges that diagnostic companies need to manage while pursuing future growth.